Cardiac risk evaluation for abdominal transplantation

Area of Science:

• Cardiology
• Transplant Medicine
• Nephrology
• Hepatology

Background:

• Cardiovascular disease (CVD) is a significant cause of death and complications in patients undergoing renal and liver transplantation.
• Current diagnostic strategies for cardiac disease in transplant candidates lack consensus and show considerable disagreement in published literature.
• The prevalence of cardiac disease is notably higher in renal and liver transplant recipients compared to the general population.

Purpose of the Study:

• To review published data on cardiac complications in renal and liver transplant patients.
• To explore reasons behind the divergent opinions on cardiac disease diagnosis and screening in this population.
• To identify the challenges in establishing effective and cost-efficient screening protocols.

Main Methods:

• Review of published observations and literature on cardiac complications in renal and liver transplant patients.
• Analysis of the predictive value of risk factors and noninvasive testing for coronary artery disease.
• Evaluation of the utility of cardiac troponin measurements in predicting outcomes.

Main Results:

• Cardiac complications significantly contribute to early mortality and graft loss post-transplant.
• Traditional cardiovascular risk factors are less predictive of coronary disease in liver transplant patients compared to renal transplant patients.
• Noninvasive stress testing shows low sensitivity for detecting coronary artery disease in both transplant groups, while cardiac troponin shows some predictive value for early mortality.

Conclusions:

• There is a lack of effective and cost-efficient methods for screening transplant patients for cardiac disease.
• Establishing widely accepted screening protocols requires defining the desired predictive power of tests in this unique patient group.
• Further research is necessary to develop and validate reliable screening strategies for cardiac disease in renal and liver transplant recipients.